Spinal Cord Astrocytes In Als is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Spinal cord astrocytes play critical roles in motor neuron support and disease progression in amyotrophic lateral sclerosis (ALS). Reactive astrocytosis is a hallmark of ALS pathology and contributes to motor neuron death through loss of supportive functions and gain of toxic properties.
| Property |
Value |
| Cell Type |
Astrocytes (Reactive/A1) |
| Location |
Spinal Cord (Ventral Horn, Gray Matter) |
| Functions |
Metabolic support, potassium buffering, glutamate uptake |
| Associated Diseases |
Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy |
| Model Systems |
SOD1 G93A mice, iPSC-derived astrocytes, astrocytes from ALS patients |
- Clear extracellular potassium during neuronal firing
- Uptake and recycling of glutamate (via GLT-1/EAAT2)
- Provide metabolic support (lactate, pyruvate)
- Maintain extracellular ion balance
- Form the glial limitans
- Interact with blood-brain barrier
- Guide neuronal migration during development
- Release gliotransmitters (ATP, D-serine, glutamate)
- Respond to neuronal activity
- Coordinate neural circuit function
-ALS astrocytes acquire a neurotoxic "A1" phenotype [1]
- Lose beneficial functions (glutamate uptake, metabolic support)
- Gain toxic functions (inflammatory cytokine release)
- This phenotype was first characterized in models of neurodegeneration
- Reduced GLT-1 expression in ALS spinal cord
- Excitotoxicity contributes to motor neuron death
-EAAT2 promoter activity is reduced
- Release of IL-1β, TNF-α, IL-6
- Complement component secretion
- Recruitment of microglia
- Mutant SOD1 expressed in astrocytes contributes to disease [2]
- Non-cell autonomous toxicity to motor neurons
- Secreted SOD1 aggregates may spread pathology
- TDP-43 aggregates in ALS astrocytes
- Loss of nuclear TDP-43 affects gene expression
- Contributes to astrocyte dysfunction
- Astrocytes with expanded repeats show dysfunction
- DPRs (dipeptide repeats) accumulate in astrocytes
- Affects neuronal support functions
- Enhance glutamate uptake (ceftriaxone upregulates GLT-1) [3]
- Block inflammatory signaling pathways
- Promote beneficial astrocyte phenotype
- Stem cell-derived astrocyte transplantation
- Induced astrocytes (iAst) from patient iPSCs
- Gene-corrected astrocytes for therapy
- BDNF and GDNF delivery via astrocytes
- Enhance metabolic coupling
- Support mitochondrial function
The study of Spinal Cord Astrocytes In Als has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Liddelow et al., 2017 - Neurotoxic reactive astrocytes
- Di Giorgio et al., 2008 - Non-cell-autonomous toxicity in SOD1 astrocytes
- Rothstein et al., 2005 - Beta-lactam antibiotics upregulate glutamate transporter